Search - tctmd.com

Displaying 101 - 120 of 764

Sort: Relevancy | Date

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

January 15, 2019

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

News Conference News AHA 2018

New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type

November 12, 2018

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Presentation TCT 2018

RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease

Presenter: James B. Hermiller Jr, Hiroki Shiomi

September 25, 2018

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Presentation TCT 2018

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Presenter: Felix Mahfoud, Patrick W. Serruys, Pieter C. Smits

September 25, 2018

Comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polimer coated everolimus-eluting Xience stent: 6- and 24-months results of the DESSOLVE III OCT sub-study

Presentation TCT Abstracts Posters 2018

Comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polimer coated everolimus-eluting Xience stent: 6- and 24-months results of the DESSOLVE III OCT sub-study

Presenter: Krzysztof Milewski

September 25, 2018

Investigation of Potential Predictors of Irregular Protrusion following Cobalt Chromium Everolimus-Eluting Stent Implantation in Patients with Stable Coronary Artery Disease : Subanalysis of the MECHANISM-Elective study

Presentation TCT Abstracts Posters 2018

Investigation of Potential Predictors of Irregular Protrusion following Cobalt Chromium Everolimus-Eluting Stent Implantation in Patients with Stable Coronary Artery Disease : Subanalysis of the MECHANISM-Elective study

Presenter: Yuya Taguchi

September 25, 2018

Randomized comparison of an everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction

Presentation TCT Abstracts Posters 2018

Randomized comparison of an everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stent in primary percutaneous coronary intervention of ST-segment elevation myocardial infarction

Presenter: Omeed Neghabat

September 25, 2018

Impact of Diabetes Mellitus on Vascular Healing Process after Everolimus-Eluting Stent Implantation: an Optical Coherence Tomography study

Presentation TCT Abstracts Posters 2018

Impact of Diabetes Mellitus on Vascular Healing Process after Everolimus-Eluting Stent Implantation: an Optical Coherence Tomography study

Presenter: Hirofumi Hioki

September 25, 2018

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

Presentation TCT 2018

ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique

Presenter: Felix Mahfoud, Patrick W. Serruys, Gregg W. Stone

September 25, 2018

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

News Conference News TCT 2018

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

Michael O'Riordan

September 22, 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

September 22, 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

News Opinion Editor's Corner TCT 2018

TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents

September 22, 2018

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Presentation TCT 2018

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Presenter: Steven R. Bailey, Patrick W. Serruys, Sorin J. Brener

September 22, 2018

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

Presentation TCT 2018

TCT-91: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis

Presenter: Alexandre Abizaid, Didier Carrié, Ariel Roguin

September 21, 2018

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Presentation TCT 2018

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Dean J. Kereiakes

September 21, 2018

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Presentation TCT 2018

TCT-62: Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Patrick W. Serruys

September 21, 2018

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

Presentation ESC 2018

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

Presenter: Holger M. Nef

August 29, 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

August 28, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.